Save the Date – Live with Leadership HIV Research for Prevention Conference

Content From: HIV.govPublished: January 22, 20212 min read


Live with Leadership

On Thursday, February 4th the Office of Infectious Disease and HIV/AIDS Policy (OIDP) will kick off the first Live with Leadership conversation in 2021 with an exciting recap from the HIV Research for Prevention ConferenceExit Disclaimer (HIV R4P). Dr. Carl Dieffenbach, Director of the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health will join Harold Phillips, Chief Operating Officer for EHE and Senior HIV Advisor for OIDP to discuss conference highlights and how the latest research can help us end HIV in the United States. The session will be held from 4:30 – 4:50 p.m. (ET).

Register NowExit Disclaimer

Live with Leadership: Continuing in 2021

The Live with Leadership series conversations provide community opportunities to hear directly from key HHS and HIV community leaders about new and ongoing work to further the goals of the Ending the HIV Epidemic (EHE) initiative. In 2020, the series included conversations held during AIDS 2020Exit Disclaimer, the National 2020 National Ryan White Conference on HIV Care and TreatmentExit Disclaimer,  the U.S. Conference on HIV/AIDS (USCHA)Exit Disclaimer and a special World AIDS DayExit Disclaimer edition. Conversations in this series are approximately 20 minutes in length and a great way to hear about EHE and key findings from HIV conferences.

Thursday, February 4th, 2021
4:30 – 4:50 pm (ET)
Click here to registerExit Disclaimer.

Registration is required for the Live with Leadership session. This event is open to everyone, please note capacity is limited so register early! This webinar will be recorded and will be available after the session for those unable to attend.

To receive timely updates on EHE, upcoming Live with Leadership sessions and more from, follow our social media channels (FacebookExit Disclaimer, TwitterExit Disclaimer, and InstagramExit Disclaimer) and sign up for updates.